Zydus Life Science incorporated a wholly owned subsidiary, ZyduS Global Treasury Centre IFSC Limited, on August 25, 2026. The entity is based in Gift City, Gandhinagar, Gujarat.

The company filed an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026.

Subsidiary Details

The new entity aims to undertake business as a Global or Regional Corporate Treasury Centre. It will carry out treasury activities and treasury services for the group.

The parent company subscribed to the entire paid-up share capital in cash. Since the subsidiary is newly incorporated, it has not commenced business operations. Its turnover is currently nil.

Regulatory Compliance

Dhaval N. Soni, Company Secretary and Compliance Officer, signed the disclosure. The filing confirms that the incorporation does not constitute a related party transaction involving promoters or group companies at the time of formation. Upon incorporation, the subsidiary becomes a related party of the listed entity.

No governmental or regulatory approvals were required for this internal corporate action.

Zydus Life Sciences disclosed the transmission of 32,577 equity shares to Prashant Babubhai Patel, a member of its promoter group. The acquisition occurred on August 19, 2026, following the death of Jasodaben Babubhai Patel, also a promoter group member. The company filed the requisite Form B under SEBI (Prohibition of Insider Trading) Regulations, 2015, with stock exchanges on August 24, 2026.

The transaction was executed off-market and did not involve any trading on recognized exchanges. Prashant Babubhai Patel held no shares in the company prior to this transmission. Post-acquisition, his holding stands at 32,577 equity shares, representing 0.00% of the company’s total paid-up capital. The intimation was received by the company on August 21, 2026.

Regulatory Disclosure Details

The filing confirms that the change in holding falls under Regulation 7(2) read with Regulation 6(2) of the PIT Regulations, which mandates continual disclosure for promoters and their relatives. No derivatives trading associated with this event was reported.

What the Numbers Show

The transmission results in a negligible change to the overall promoter group stake structure, given the 0.00% impact on total shareholding. This indicates that the transfer is likely an internal realignment within the promoter family rather than a strategic shift in control or ownership concentration at the group level. The absence of any open market activity suggests the transaction was settled purely through legal succession processes without impacting secondary market liquidity or price discovery mechanisms.